Biotechnology in Italy

Biotechnology in Italy

Summary

Biotechnology in Italy industry profile provides top-line qualitative and quantitative summary information including: market size (value 2019-24, and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

  • Biotechnology market encompasses a broad range of technologies, products, and services that utilize biological systems, organisms, or derivatives to develop or modify processes or products for specific applications. Market value refers to the revenue generated from product sales, licensing fees, royalties, and research funding.
  • The Italian biotechnology market recorded revenues of $14.8 billion in 2024, representing a compound annual growth rate (CAGR) of 3.5% between 2019 and 2024.
  • The environment & industrial processing segment accounted for the market's largest proportion in 2024, with total revenues of $4.1 billion, equivalent to 28.1% of the market's overall value.
  • In 2024, the Italian biotechnology market recorded an annual growth of 5.0% due to advancements in genetic research. For instance, in June 2024, the University of Milan launched the first field trial of gene-edited crops in Italy for a new rice variety called RIS8imo.
Scope
  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the biotechnology market in Italy
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Italy
  • Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the Italy biotechnology market with five year forecasts
Reasons to Buy
  • What was the size of the Italy biotechnology market by value in 2024?
  • What will be the size of the Italy biotechnology market in 2029?
  • What factors are affecting the strength of competition in the Italy biotechnology market?
  • How has the market performed over the last five years?
  • How large is Italy’s biotechnology market in relation to its regional counterparts?


1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
4 Market Segmentation
4.1. Category segmentation
4.2. Geography segmentation
5 Market Outlook
5.1. Market value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the key players?
7.2. What strategies do the key players follow?
7.3. What have been the most recent market developments?
8 Company Profiles
8.1. A. Menarini Industrie Farmaceutiche Riunite Srl
8.2. DiaSorin SpA
8.3. AGC Biologics SpA
8.4. Philogen SpA
8.5. Arterra Bioscience srl
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
List of Tables
Table 1: Italy biotechnology industry value: $ million, 2019-24
Table 2: Italy biotechnology industry category segmentation: % share, by value, 2019-24
Table 3: Italy biotechnology industry category segmentation: $ million, 2019-24
Table 4: Italy biotechnology industry geography segmentation: $ million, 2024
Table 5: Italy biotechnology industry value forecast: $ million, 2024-29
Table 6: A. Menarini Industrie Farmaceutiche Riunite Srl: Key Facts
Table 7: A. Menarini Industrie Farmaceutiche Riunite Srl: Key Employees
Table 8: DiaSorin SpA: Key Facts
Table 9: DiaSorin SpA: Annual Financial Ratios
Table 10: DiaSorin SpA: Key Employees
Table 11: AGC Biologics SpA: Key Facts
Table 12: AGC Biologics SpA: Key Employees
Table 13: Philogen SpA: Key Facts
Table 14: Philogen SpA: Annual Financial Ratios
Table 15: Philogen SpA: Key Employees
Table 16: Arterra Bioscience srl: Key Facts
Table 17: Arterra Bioscience srl: Annual Financial Ratios
Table 18: Arterra Bioscience srl: Key Employees
Table 19: Italy Size of Population (Million), 2019-24
Table 20: Italy Real GDP (Constant 2010 Prices, $ Billion), 2019-24
Table 21: Italy GDP (Current Prices, $ Billion), 2019-24
Table 22: Italy Inflation, 2019-24
Table 23: Italy Consumer Price Index (Absolute), 2019-24
Table 24: Italy Exchange Rate, 2019-24
List of Figures
Figure 1: Italy biotechnology industry value: $ million, 2019-24
Figure 2: Italy biotechnology industry category segmentation: $ million, 2019-24
Figure 3: Italy biotechnology industry geography segmentation: % share, by value, 2024
Figure 4: Italy biotechnology industry value forecast: $ million, 2024-29
Figure 5: Forces driving competition in the biotechnology industry in Italy, 2024
Figure 6: Drivers of buyer power in the biotechnology industry in Italy, 2024
Figure 7: Drivers of supplier power in the biotechnology industry in Italy, 2024
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Italy, 2024
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Italy, 2024
Figure 10: Drivers of degree of rivalry in the biotechnology industry in Italy, 2024

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings